• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

You and Eye: Unearthing the true prevalence of keratoconus - with Andrew S. Morgenstern, OD, FAAO, FNAP

News
Podcast

Andrew S. Morgenstern, OD, FAAO, FNAP, joins Dr. Korik to discuss a newly published study on the incidence of keratoconus among pediatric patients in a Chicago-based study. The pair also discuss the International Keratoconus Academy, and Morgenstern's experience working at Walter Reed Medical Center.

Andrew S. Morgenstern, OD, FAAO, FNAP, joins Dr. Korik to discuss a newly published study on the incidence of keratoconus among pediatric patients in a Chicago-based study. The pair also discuss the International Keratoconus Academy, and Dr. Morgenstern's experience working at Walter Reed Medical Center.

*Editor's note: Around 8:47, Dr. Korik says corneal crosslinking was not in the US as of 2013. However, it was being used off-label at that time but had not been FDA approved for keratoconus.

To learn more about IKA or to join the organization, visit their website: https://www.keratoconusacademy.com/

Prefer to listen on the go? You can follow the podcast on Spotify and Apple Podcasts.

Follow Dr Korik on social media:
Instagram: @mirrrcatt, @dr_miri_k
Facebook: https://www.facebook.com/msk1010xoxo
LinkedIn: https://www.linkedin.com/in/miriam-korik-81b492111/
YouTube: https://www.youtube.com/channel/UCuIVJVZ17AJFEo8fqXK_gZg

Related Videos
Amy Butler of Bausch + Lomb details the company's recycling programs and initiatives for contact lenses and other eye care products
Neda Shamie, MD, details the upcoming CIME 2024 meeting
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.